I gave a seminar last week for the UW computer scientists interested in doing good with technology. It’s a fun crowd. Here are the slides, requested by a regular attendee who couldn’t be there.
Category Archives: global health
I’ve been developing a habit of comparing health statistics I hear in the media with the results in GBD Compare. It is nice when they agree, such as in a recent ScienceMag focus on chronic kidney disease, corroborated here: http://ihmeuw.org/1v7i . It would be even better if the cause was known, and the burden could be removed.
I have fallen way behind in noting the IHME weekly seminars, but I was just thinking of this wonderful one from last semester, and I couldn’t wait any longer to link to it: Overdiagnosed: Making people sick in the pursuit of health by H. Gilbert Welch.
I’m away from work for some really exciting family stuff, but while I wait on that, our paper on trends in smoking prevalence has just come out, along with a fun interactive data visualization of the results, and some media coverage that I think tells the story quite well.
What makes this work methodologically challenging is that the data comes from telephone surveys, but people who smoke stopped using landlines more than people who don’t smoke:
Last week I gave a talk on my work on the Iraq mortality survey. It was the first time that I’ve had a chance to talk about it since our paper was published. And since the data is all online and the scientific python tools are getting slick, I was able to make charts like this one:
GBD 2010: The Global Burden of Ischemic Heart Disease in 1990 and 2010: The Global Burden of Disease 2010 Study
I wish I had been more diligent in collecting the disease-specific papers that have come out following the Global Burden of Disease 2010 Study… here is the latest one to go into print: Moran et al, The Global Burden of Ischemic Heart Disease in 1990 and 2010: The Global Burden of Disease 2010 Study, in Circulation.
Journal Club: Transmission Assessment Surveys (TAS) to Define Endpoints for Lymphatic Filariasis Mass Drug Administration: A Multicenter Evaluation
While I’m catching up on journal club reading, two weeks ago we discussed Chu et al, Transmission Assessment Surveys (TAS) to Define Endpoints for Lymphatic Filariasis Mass Drug Administration: A Multicenter Evaluation, which takes on the question of how to decide when it is safe to stop a massive disease elimination program. This work must rely on some cool mathematical epi modeling, to say how many years of what level of coverage is necessary before you can hope the LF is gone.